Author information:
(1)Molecular Pathology Section, Laboratory of Immunogenetics, National Institute 
of Allergy and Infectious Diseases, National Institutes of Health, Rockville, 
MD, 20852, USA.
(2)Ludwig Institute for Cancer Research, 9500 Gilman Drive, La Jolla, CA, 92093, 
USA.
(3)Department of Cellular and Molecular Medicine, Institute of Genomic Medicine, 
Moores Cancer Center, San Diego School of Medicine, University of California, 
San Diego, La Jolla, CA, 92093, USA.
(4)Stem Cell Project, Tokyo Metropolitan Institute of Medical Science, 
Kamikitazawa, Setagaya-ku, Tokyo, Japan.
(5)Bioinformatics and Computational Biosciences Branch, Office of Cyber 
Infrastructure and Computational Biology, National Institute of Allergy and 
Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.
(6)Guangzhou Institutes of Biomedicine and Health, Molecular Epigenetics 
Laboratory, 190 Kai Yuan Avenue, Science Park, Guangzhou, 510530, China.
(7)Gene and Stem Cell Therapy Program, Centenary Institute, Camperdown, NSW, 
2050, Australia.
(8)Sydney Medical School, University of Sydney, Sydney, NSW, 2006, Australia.
(9)Cell and Molecular Therapies, Royal Prince Alfred Hospital, Camperdown, NSW, 
2050, Australia.
(10)Ludwig Institute for Cancer Research, 9500 Gilman Drive, La Jolla, CA, 
92093, USA. biren@ucsd.edu.
(11)Department of Cellular and Molecular Medicine, Institute of Genomic 
Medicine, Moores Cancer Center, San Diego School of Medicine, University of 
California, San Diego, La Jolla, CA, 92093, USA. biren@ucsd.edu.
(12)Molecular Pathology Section, Laboratory of Immunogenetics, National 
Institute of Allergy and Infectious Diseases, National Institutes of Health, 
Rockville, MD, 20852, USA. vlobanenkov@mail.nih.gov.